HomeNewsWorldCoronavirus update: In a first, 33-year-old man from Hong Kong gets re-infected with COVID-19

Coronavirus update: In a first, 33-year-old man from Hong Kong gets re-infected with COVID-19

Genetic tests revealed that the 33-year-old Hong Kong man had a different strain of the coronavirus than the one he was previously been infected with.

August 25, 2020 / 16:02 IST
Story continues below Advertisement
Representative image
Representative image

In a first such documented case, a 33-year-old Hong Kong man has tested positive for coronavirus after recovering from the same. The man tested positive for COVID-19 after returning from a trip to Spain in mid-August.

He was symptomatic the first time around, but no obvious symptoms were reported the second time, the team at the University of Hong Kong reported, as per a CNN report.

Story continues below Advertisement

"The patient got re-infected 4.5 months after the first infection. Therefore, it shows that for this patient, the immunity induced by the first infection is short-lasting," Dr Kelvin Kai-Wang To of the University of Hong Kong, who worked on the study, said, as per the report.

The first infection was from a strain of the coronavirus most closely related to strains from the United States or England, and the second infection was most closely related to strains from Switzerland and England, researchers said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show